FDA officials shared their insights on how drug makers can be more efficient when developing treatments for rare diseases, according to comments at the National Organization for Rare Disorders (NORD) Summit in Washington, DC. Despite the growing number of new…
Subscribe to our Newsletter
Be the first to know the latest trends in clinical research, real-world case studies, and industry secrets.
[fluentform id="3"]
ProRelix Research is the rapidly growing Contract/ Clinical Research Organization (CRO) with multi-country service capability supporting phase 1, 2, 3, & 4 clinical trials of Pharma, Biotech, Biopharma, Medical Device, Nutraceutical & Herbal companies to conduct in the USA, India, Europe & South East Asia.